Neuraxis is a biotechnology business based in the US. Neuraxis shares (NRXS) are listed on the NYSE MKT and all prices are listed in US Dollars. Neuraxis employs 19 staff and has a trailing 12-month revenue of around $2.3 million.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $3.00 |
|---|---|
| 52-week range | $1.80 - $5.20 |
| 50-day moving average | $3.06 |
| 200-day moving average | $2.97 |
| Wall St. target price | $7.50 |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $-2.23 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $3 from 2024-09-17
| 1 week (2024-09-12) | -3.23% |
|---|---|
| 1 month (2024-08-19) | -5.66% |
| 3 months (2024-06-18) | 7.14% |
| 6 months (2024-03-19) | -10.71% |
| 1 year (2023-09-15) | N/A |
|---|---|
| 2 years (2022-09-15) | N/A |
| 3 years (2021-09-15) | N/A |
| 5 years (2019-09-15) | N/A |
| Revenue TTM | $2.3 million |
|---|---|
| Gross profit TTM | $0 |
| Return on assets TTM | -260.29% |
| Return on equity TTM | 0% |
| Profit margin | 0% |
| Book value | $-0.77 |
| Market Capitalization | $21.6 million |
TTM: trailing 12 months
We're not expecting Neuraxis to pay a dividend over the next 12 months.
NeurAxis, Inc. , a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome. The company sells its products to healthcare companies, including hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022.
Compare, choose and apply for a certificate of deposit on finder.com. Competitive interest rates from leading financial institutions in the US.
Robinhood’s Roth IRAs are some of the best and stand out for their low trading costs, access to options trading and a 3% IRA match.
Chime provides legitimate banking services through partner banks, which also offer typical FDIC insurance up to $250,000. See our full review here.
An interval fund is a type of closed-end mutual fund that allows you to buy shares that can only be sold back to the fund during specific intervals.
Compare cash advance apps that offer $200 advances and the requirements needed to qualify.
Compare cash advance apps based on monthly fees, transfer fees and advance amounts.
A guide to cash advance providers that offer $100 advances and what you need to qualify.
Compare cash advance apps that offer $1,000 cash advances with no credit check, plus how to qualify.
Robinhood Gold costs $5/month. The cost is worth it if you take advantage of the IRA match, margin interest savings and bonus on taxable deposits.
The highest CD rates in Texas are from Ciera Bank, Quontic Bank, Susser Bank, Ally Bank and more. See the full list here.